Is ‘conflict of interest’ a Misnomer? Managing interests in immunization research and evaluation

Elisabeth McClymont; Jason Brophy; Vinita Dubey; Jeff Kwong; Samantha Meyer; Natasha Crowcroft; Scott Halperin; Shannon MacDonald; Karen Simmons; Karina Top; Brian Ward; Manish Sadarangani

doi:10.1080/21645515.2021.1879580

Is ‘conflict of interest’ a Misnomer? Managing interests in immunization research and evaluation

Elisabeth McClymont, Jason Brophy, Vinita Dubey, Jeff Kwong, Samantha Meyer, Natasha Crowcroft, Scott Halperin, Shannon MacDonald, Karen Simmons, Karina Top, Brian Ward, Manish Sadarangani

Medicine

Producción científica: Contribución a una revista › Comentario/debate › revisión exhaustiva

2 Citas (Scopus)

Resumen

Potential conflicts of interest in vaccine research can lead to negative consequences that undermine public trust and thereby put communities at risk. However, collaborations that may give rise to potential conflicts between interests can also greatly facilitate appropriate, scientifically robust, and timely vaccine development, implementation, and evaluation. At present, policies regarding the management of potential conflicts between interests are not ideal. To optimally manage interests in vaccine research, we recommend acknowledging all forms of interests and treating them all as relevant, developing appropriate collaborations, referring to all “conflicts of interest” simply as “interests” or “declarations,” and promoting transparency through developing consistent reporting mechanisms.

Idioma original	English
Número de artículo	1879580
Publicación	Human Vaccines and Immunotherapeutics
Volumen	18
N.º	1
DOI	https://doi.org/10.1080/21645515.2021.1879580
Estado	Published - 2022

Nota bibliográfica

Funding Information:
EM receives salary support from the Canadian HIV Trials Network and the Michael Smith Foundation for Health Research. EM has also received grant funding from Lundbeck Fonden and has been a co-investigator on grants from the Canadian Institutes of Health Research, the BC Women’s Foundation, and the Public Health Agency of Canada.

Funding Information:
NC discloses a professional interest in maximizing the health benefits of vaccines for which NC has received salary from government sources in the UK and Canada either directly or indirectly (via arm’s length agencies of government). NC has also won competitive research funding from CIHR, PHAC and other sources. The governments that fund the agencies for which NC has worked make decisions on whether and which vaccines will be funded for their populations. They may seek expert advice from individuals such as NC but may not follow that advice.

Funding Information:
SMacDonald is supported by a salary award from the Canadian Child Health Clinician Scientist Program. She has received research operating grants from national and provincial government funding sources.

Funding Information:
KT has received grants from GSK outside the submitted work.

Funding Information:
MS is supported via salary awards from the BC Children’s Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments.

Publisher Copyright:
© 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.

ASJC Scopus Subject Areas

Immunology and Allergy
Immunology
Pharmacology

PubMed: MeSH publication types

Journal Article

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1080/21645515.2021.1879580

Otros archivos y enlaces

Citar esto

McClymont, E., Brophy, J., Dubey, V., Kwong, J., Meyer, S., Crowcroft, N., Halperin, S., MacDonald, S., Simmons, K., Top, K., Ward, B., & Sadarangani, M. (2022). Is ‘conflict of interest’ a Misnomer? Managing interests in immunization research and evaluation. Human Vaccines and Immunotherapeutics, 18(1), Artículo 1879580. https://doi.org/10.1080/21645515.2021.1879580

@article{90036e6070eb4adda142c51bb47514e8,

title = "Is {\textquoteleft}conflict of interest{\textquoteright} a Misnomer? Managing interests in immunization research and evaluation",

abstract = "Potential conflicts of interest in vaccine research can lead to negative consequences that undermine public trust and thereby put communities at risk. However, collaborations that may give rise to potential conflicts between interests can also greatly facilitate appropriate, scientifically robust, and timely vaccine development, implementation, and evaluation. At present, policies regarding the management of potential conflicts between interests are not ideal. To optimally manage interests in vaccine research, we recommend acknowledging all forms of interests and treating them all as relevant, developing appropriate collaborations, referring to all “conflicts of interest” simply as “interests” or “declarations,” and promoting transparency through developing consistent reporting mechanisms.",

author = "Elisabeth McClymont and Jason Brophy and Vinita Dubey and Jeff Kwong and Samantha Meyer and Natasha Crowcroft and Scott Halperin and Shannon MacDonald and Karen Simmons and Karina Top and Brian Ward and Manish Sadarangani",

note = "Funding Information: EM receives salary support from the Canadian HIV Trials Network and the Michael Smith Foundation for Health Research. EM has also received grant funding from Lundbeck Fonden and has been a co-investigator on grants from the Canadian Institutes of Health Research, the BC Women{\textquoteright}s Foundation, and the Public Health Agency of Canada. Funding Information: NC discloses a professional interest in maximizing the health benefits of vaccines for which NC has received salary from government sources in the UK and Canada either directly or indirectly (via arm{\textquoteright}s length agencies of government). NC has also won competitive research funding from CIHR, PHAC and other sources. The governments that fund the agencies for which NC has worked make decisions on whether and which vaccines will be funded for their populations. They may seek expert advice from individuals such as NC but may not follow that advice. Funding Information: SMacDonald is supported by a salary award from the Canadian Child Health Clinician Scientist Program. She has received research operating grants from national and provincial government funding sources. Funding Information: KT has received grants from GSK outside the submitted work. Funding Information: MS is supported via salary awards from the BC Children{\textquoteright}s Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments. Publisher Copyright: {\textcopyright} 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.",

year = "2022",

doi = "10.1080/21645515.2021.1879580",

language = "English",

volume = "18",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Landes Bioscience",

number = "1",

}

TY - JOUR

T1 - Is ‘conflict of interest’ a Misnomer? Managing interests in immunization research and evaluation

AU - McClymont, Elisabeth

AU - Brophy, Jason

AU - Dubey, Vinita

AU - Kwong, Jeff

AU - Meyer, Samantha

AU - Crowcroft, Natasha

AU - Halperin, Scott

AU - MacDonald, Shannon

AU - Simmons, Karen

AU - Top, Karina

AU - Ward, Brian

AU - Sadarangani, Manish

N1 - Funding Information: EM receives salary support from the Canadian HIV Trials Network and the Michael Smith Foundation for Health Research. EM has also received grant funding from Lundbeck Fonden and has been a co-investigator on grants from the Canadian Institutes of Health Research, the BC Women’s Foundation, and the Public Health Agency of Canada. Funding Information: NC discloses a professional interest in maximizing the health benefits of vaccines for which NC has received salary from government sources in the UK and Canada either directly or indirectly (via arm’s length agencies of government). NC has also won competitive research funding from CIHR, PHAC and other sources. The governments that fund the agencies for which NC has worked make decisions on whether and which vaccines will be funded for their populations. They may seek expert advice from individuals such as NC but may not follow that advice. Funding Information: SMacDonald is supported by a salary award from the Canadian Child Health Clinician Scientist Program. She has received research operating grants from national and provincial government funding sources. Funding Information: KT has received grants from GSK outside the submitted work. Funding Information: MS is supported via salary awards from the BC Children’s Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments. Publisher Copyright: © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.

PY - 2022

Y1 - 2022

N2 - Potential conflicts of interest in vaccine research can lead to negative consequences that undermine public trust and thereby put communities at risk. However, collaborations that may give rise to potential conflicts between interests can also greatly facilitate appropriate, scientifically robust, and timely vaccine development, implementation, and evaluation. At present, policies regarding the management of potential conflicts between interests are not ideal. To optimally manage interests in vaccine research, we recommend acknowledging all forms of interests and treating them all as relevant, developing appropriate collaborations, referring to all “conflicts of interest” simply as “interests” or “declarations,” and promoting transparency through developing consistent reporting mechanisms.

AB - Potential conflicts of interest in vaccine research can lead to negative consequences that undermine public trust and thereby put communities at risk. However, collaborations that may give rise to potential conflicts between interests can also greatly facilitate appropriate, scientifically robust, and timely vaccine development, implementation, and evaluation. At present, policies regarding the management of potential conflicts between interests are not ideal. To optimally manage interests in vaccine research, we recommend acknowledging all forms of interests and treating them all as relevant, developing appropriate collaborations, referring to all “conflicts of interest” simply as “interests” or “declarations,” and promoting transparency through developing consistent reporting mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=85125987548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125987548&partnerID=8YFLogxK

U2 - 10.1080/21645515.2021.1879580

DO - 10.1080/21645515.2021.1879580

M3 - Comment/debate

C2 - 33651972

AN - SCOPUS:85125987548

SN - 2164-5515

VL - 18

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 1

M1 - 1879580

ER -

Is ‘conflict of interest’ a Misnomer? Managing interests in immunization research and evaluation

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

PubMed: MeSH publication types

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto